Literature DB >> 973957

Can digoxin dose requirements be predicted?

S M Dobbs, G E Mawer, M Rodgers, B G Woodcock, S B Lucas.   

Abstract

A search for patient variables relevant to digoxin dose requirements was made in fourty-three patients with a wide range of renal and hepatic function. The daily dose of digoxin to achieve a mean serum concentration of 1.5 ng/ml, the standardized dose, was calculated for each patient. The standardized dose correlated significantly with the following variables, in descending order of correlation coefficient; creatinine clearance, serum creatinine concentration, body weight and serum albumin concentration. An equation containing the two independent variables, creatinine clearance and serum albumin concentration, had a significantly stronger correlation with standardized dose than creatinine clearance alone. Attempts were made in each patient to predict the standardized dose using both empirical prescribing methods and the published nomograms. Although a maximum of 70% of the variance of the standardized dose was explained, this corresponded approximately to one patient in three having a predicted dose outside the 95% confidnece limits for the standardized dose. There remain important sources of individual variation in digoxin dose requirements yet to be identified. Future application of empirical prescribing methods, such as multiple linear regression and Bayes' theorem, to prescription for large, defined patient groups may improve dose prediction for individual patients.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 973957      PMCID: PMC1428871          DOI: 10.1111/j.1365-2125.1976.tb00597.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  21 in total

1.  A mathematical approach to medical diagnosis. Application to congenital heart disease.

Authors:  H R WARNER; A F TORONTO; L G VEASEY; R STEPHENSON
Journal:  JAMA       Date:  1961-07-22       Impact factor: 56.272

Review 2.  A nomogram for digoxin therapy.

Authors:  R W Jelliffe; G Brooker
Journal:  Am J Med       Date:  1974-07       Impact factor: 4.965

3.  Differences in serum digoxin concentrations between outpatients and inpatients: an effect of compliance?

Authors:  L B Sheiner; B Rosenberg; V V Marathe; C Peck
Journal:  Clin Pharmacol Ther       Date:  1974-03       Impact factor: 6.875

4.  Letter: Plasma-digoxin concentrations after an intravenous loading dose.

Authors:  A Bertler; B Bergdahl; E Karlsson
Journal:  Lancet       Date:  1974-10-19       Impact factor: 79.321

5.  Rapid evaluation of creatinine clearance.

Authors:  K Siersbaek-Nielsen; J M Hansen; J Kampmann; M Kristensen
Journal:  Lancet       Date:  1971-05-29       Impact factor: 79.321

6.  Multiple dose kinetics and drug dosage in patients with kidney disease.

Authors:  L Dettli; P Spring; S Ryter
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1971

7.  Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay.

Authors:  T W Smith; V P Butler; E Haber
Journal:  N Engl J Med       Date:  1969-11-27       Impact factor: 91.245

8.  Measurement of plasma digoxin concentration by radioimmunoassay.

Authors:  D C Evered; C Chapman; C J Hayter
Journal:  Br Med J       Date:  1970-08-22

9.  Relationship of the excretion of tritiated digoxin to renal function.

Authors:  P M Bloom; W B Nelp; S H Tuell
Journal:  Am J Med Sci       Date:  1966-02       Impact factor: 2.378

10.  Use of sequential Bayesian model in diagnosis of jaundice by computer.

Authors:  R P Knill-Jones; R B Stern; D H Girmes; J D Maxwell; R P Thompson; R Williams
Journal:  Br Med J       Date:  1973-03-03
View more
  22 in total

1.  Serum digoxin concentrations.

Authors:  S M Dobbs; E M Rodgers; G E Mawer; W I Kenyon
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

2.  Digoxin: linearity between dose and serum concentration.

Authors:  S M Dobbs; J Parkes; E M Rodgers
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

3.  Equivalence of lanoxin tablets.

Authors:  S M Dobbs; E M Rodgers; B G Woodcock
Journal:  Br J Clin Pharmacol       Date:  1976-06       Impact factor: 4.335

4.  Evaluation of digoxin capsules in outpatients.

Authors:  E M Rodgers; S M Dobbs; W I Kenyon; J W Poston
Journal:  Br Med J       Date:  1977-07-23

5.  Influence of diet on digoxin dose requirements.

Authors:  J Turner; S M Dobbs; P W Nicholson; A P McGill; E M Rodgers
Journal:  Br J Clin Pharmacol       Date:  1977-08       Impact factor: 4.335

6.  Prediction of digoxin dose requirements.

Authors:  S M Dobbs; G E Mawer
Journal:  Clin Pharmacokinet       Date:  1977 Jul-Aug       Impact factor: 6.447

Review 7.  Clinical pharmacokinetics of digoxin.

Authors:  E Iisalo
Journal:  Clin Pharmacokinet       Date:  1977 Jan-Feb       Impact factor: 6.447

8.  Maintenance digoxin after an episode of heart failure: placebo-controlled trial in outpatients.

Authors:  S M Dobbs; W I Kenyon; R J Dobbs
Journal:  Br Med J       Date:  1977-03-19

Review 9.  Computer assisted prescribing of drugs.

Authors:  G E Mawer
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

Review 10.  Pharmacokinetics in patients with cardiac failure.

Authors:  N L Benowitz; W Meister
Journal:  Clin Pharmacokinet       Date:  1976 Nov-Dec       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.